Roza Chaireti

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: CANCERS. 2024;16(14):2511
Incidence and Risk Factors for Arterial Thrombosis in Patients with Acute Leukemia and Lymphoid Malignancies: A Retrospective Single-Center Study
Hellman J; Chaireti R
Article: CLINICAL AND APPLIED THROMBOSIS/HEMOSTASIS. 2024;30:10760296241260053
Global Hemostatic Methods to Tailor Treatment With Bypassing Agents in Hemophilia A With Inhibitors-A Single-Center, Pilot Study
Chaireti R; Soutari N; Holmstrom M; Petrini P; Magnusson M; Ranta S; Pruner I; Antovic JP
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2023;201(2):326-333
Acquired Haemophilia A in four north European countries: survey of 181 patients
Lindahl R; Nummi V; Lehtinen A-E; Szanto T; Hiltunen L; Olsson A; Glenthoej A; Chaireti R; Vaide I; Funding E; Zetterberg E
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2022;109(6):749-754
Conditioning with melphalan 200 mg/m² and subsequent ASCT improves progression-free and overall survival in elderly myeloma patients compared to standard of care
Afram G; Chaireti R; Uttervall K; Luong V; Lund J; Kashif M; Gahrton G; Alici E; Nahi H
Journal article: HEMATO. 2022;3(3):518-526
Risk Factors and Risk Stratification of Thromboembolic Risk in Patients with Multiple Myeloma
Chaireti R; Nahi H; Mazzucato M
Article: LUPUS. 2021;30(7):1031-1038
The presence of lupus nephritis additionally increases the risk of preeclampsia among pregnant women with systemic lupus erythematosus
Bremme K; Honkanen S; Gunnarsson I; Chaireti R
Article: JOURNAL OF MATERNAL-FETAL AND NEONATAL MEDICINE. 2021;34(10):1641-1644
Obstetric and neonatal outcomes in pregnant women treated with high-dose thromboprophylaxis: a retrospective, single-center study
Bremme K; Lannemyr A; Tyni L; Chaireti R
Article: THROMBOSIS AND HAEMOSTASIS. 2021;121(01):27-35
Genetics and Hemostatic Potential in Persons with Mild to Moderate Hemophilia A with a Discrepancy between One-Stage and Chromogenic FVIII Assays
Stralfors A; Mikovic D; Schmidt D; Onelov L; Soutari NMH; Berndtson M; Chaireti R; Holmstrom M; Antovic JP; Bruzelius M
Article: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2020;18(10):2582-2589
Management and outcomes of newborns at risk for inherited antithrombin deficiency
Chaireti R; Tronnhagen I; Bremme K; Ranta S
Article: SCIENTIFIC REPORTS. 2020;10(1):7871
Phosphatidylserine positive microparticles improve hemostasis in in-vitro hemophilia A plasma models
Zong Y; Pruner I; Antovic A; Taxiarchis A; Vila ZP; Soutari N; Mobarrez F; Chaireti R; Widengren J; Piguet J; Antovic JP
Article: JOURNAL OF ELECTROCARDIOLOGY. 2020;58:171-175
Substantial prevalence of subclinical cardiovascular diseases in patients with hemophilia A evaluated by advanced electrocardiography
Zong Y; Maanja M; Chaireti R; Schlegel TT; Ugander M; Antovic JP
Article: LUPUS. 2019;28(7):868-877
Obstetric outcomes in patients with primary thrombotic and obstetric antiphospholipid syndrome and its relation to the antiphospholipid antibody profile
Hogden A; Antovic A; Berg E; Bremme K; Chaireti R
Article: THROMBOSIS RESEARCH. 2019;178:34-40
Correlation of thromboelastography and thrombin generation assays in warfarin-treated patients
Schmidt DE; Chaireti R; Bruzelius M; Holmstrom M; Antovic J; Agren A
Article: HAEMOPHILIA. 2019;25(2):334-342
Evaluation of a standardized protocol for thrombin generation using the calibrated automated thrombogram: A Nordic study
Ljungkvist M; Strandberg K; Berntorp E; Chaireti R; Holme PA; Larsen OH; Lassila R; Jouppila A; Szanto T; Zetterberg E
Article: PLOS ONE. 2019;14(1):e0210544
Blood inflammatory and endothelial markers in women with von Willebrand disease
Govorov I; Bremme K; Larsson A; Holmstrom M; Komlichenko E; Chaireti R; Mints M
Article: SCIENTIFIC REPORTS. 2018;8(1):17467
Thrombin generation during a regular menstrual cycle in women with von Willebrand disease
Govorov I; Bremme K; Lindahl TL; Holmstrom M; Komlichenko E; Chaireti R; Mints M
Article: BLOOD. 2017;130(15):1706-1712
Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study
Majeed A; Agren A; Holmstrom M; Bruzelius M; Chaireti R; Odeberg J; Hempel E-L; Magnusson M; Frisk T; Schulman S
Article: EXPERIMENTAL AND THERAPEUTIC MEDICINE. 2016;11(5):1923-1929
Heavy menstrual bleeding and health-associated quality of life in women with von Willebrand's disease
Govorov I; Ekelund L; Chaireti R; Elfvinge P; Holmstrom M; Bremme K; Mints M
Article: SCANDINAVIAN JOURNAL OF CLINICAL AND LABORATORY INVESTIGATION. 2016;76(3):190-194
Inflammatory and endothelial markers during the menstrual cycle
Chaireti R; Lindahl TL; Bystrom B; Bremme K; Larsson A
Article: PLOS ONE. 2016;11(10):e0164683
Postpartum Hemorrhage in Women with Von Willebrand Disease - A Retrospective Observational Study
Govorov I; Lofgren S; Chaireti R; Holmstrom M; Bremme K; Mints M
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2015;94(4):355-362
TP53 mutations and MDM2^SNP309 identify subgroups of AML patients with impaired outcome
Falk IJ; Willander K; Chaireti R; Lund J; Nahi H; Hermanson M; Green H; Lotfi K; Soderkvist P
Journal article: JOURNAL OF HEMATOLOGY. 2015;4(3):202-204
Management of a Patient With Subdural Hematoma Complicated by the Presence of Heparin-Induced and Suspected Concomitant Immune Thrombocytopenia: A Case Report
Chaireti R; Gkasiamis A; Lindahl TL
Article: THROMBOSIS RESEARCH. 2014;134(2):455-461
Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event
Chaireti R; Rajani R; Bergquist A; Melin T; Friis-Liby I-L; Kapraali M; Kechagias S; Lindahl TL; Almer S
Article: BIOMARKER RESEARCH. 2014;2:18
Mutations in the isocitrate dehydrogenase 2 gene and IDH1 SNP 105C > T have a prognostic value in acute myeloid leukemia.
Willander K; Falk IJ; Chaireti R; Paul E; Hermansson M; Gréen H; Lotfi K; Söderkvist P
Article: HUMAN REPRODUCTION. 2013;28(7):1846-1852
Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle
Chaireti R; Gustafsson KM; Bystrom B; Bremme K; Lindahl TL
Article: THROMBOSIS RESEARCH. 2013;131(2):135-139
Is thrombin generation at the time of an acute thromboembolic episode a predictor of recurrence? The LInkoping Study on Thrombosis (LIST) - A 7-year follow-up
Chaireti R; Jennersjo C; Lindahl TL
Article: THROMBOSIS RESEARCH. 2009;124(2):178-184
Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study
Chaireti R; Jennersjo C; Lindahl TL
Article: DIGESTIVE DISEASES AND SCIENCES. 2007;52(9):2351-2358
Effect of 5-HT₂ receptor blockade on cadmium-induced acute toxicity
Tzirogiannis KN; Demonakou MD; Papadimas GK; Skaltsas SD; Manta GA; Kourentzi KT; Alexandropoulou KN; Hereti RI; Mykoniatis MG; Panoutsopoulos GI
Article: DIGESTIVE DISEASES AND SCIENCES. 2006;51(11):1998-2006
Peliosis hepatis: Microscopic and macroscopic type, time pattern, and correlation with liver cell apoptosis in a model of toxic liver injury
Tzirogiannis KN; Papadimas GK; Kondyli VG; Kourentzi KT; Demonakou MD; Kyriakou LG; Mykoniatis MG; Hereti RI; Panoutsopoulos GI
Article: LIVER INTERNATIONAL. 2006;26(3):352-361
Effect of serotonin receptor 2 blockage on liver regeneration after partial hepatectomy in the rat liver
Papadimas GK; Tzirogiannis KN; Panoutsopoulos GI; Demonakou MD; Skaltsas SD; Hereti RI; Papadopoulou-Daifoti Z; Mykoniatis MG
Article: IN VIVO. 2005;19(5):841-847
The effect of hepatic stimulator substance (HSS) on liver regeneration arrest induced by 5-HT₂ receptor blockade
Tzirogiannis KN; Panoutsopoulos GI; Papadimas GK; Demonakou MD; Hereti RI; Manta GA; Kourentzi KT; Kondili VG; Alexandropoulou KN; Mykoniatis MG
Article: IN VIVO. 2005;19(4):695-704
The role of hepatic stimulator substance (HSS) on liver regeneration arrest induced by cadmium
Tzirogiannis KN; Papadimas GK; Kourentzi KT; Kondili VG; Androutsos CD; Hereti RI; Triantaphyllou MI; Panoutsopoulos GI
Article: DIGESTIVE DISEASES AND SCIENCES. 2005;50(2):297-307
The hepatoprotective effect of hepatic stimulator substance (HSS) against liver regeneration arrest induced by acute ethanol intoxication
Kondili VG; Tzirogiannis KN; Androutsos CD; Papadimas GK; Demonakou MD; Hereti RI; Manta GA; Kourentzi KT; Triantaphyllou MI; Panoutsopoulos GI
Article: ARCHIVES OF TOXICOLOGY. 2004;78(6):321-329
The hepatoprotective effect of putrescine against cadmium-induced acute liver injury
Tzirogiannis KN; Panoutsopoulos GI; Demonakou MD; Papadimas GK; Kondyli VG; Kourentzi KT; Hereti RI; Mykoniatis MG
Article: DIGESTIVE DISEASES AND SCIENCES. 2004;49(6):1019-1028
Effect of hepatic stimulator substance (HSS) on cadmium-induced acute hepatotoxicity in the rat liver
Tzirogiannis KN; Panoutsopoulos GI; Demonakou MD; Hereti RI; Alexandropoulou KN; Mykoniatis MG
Article: ARCHIVES OF TOXICOLOGY. 2003;77(12):694-701
Time-course of cadmium-induced acute hepatotoxicity in the rat liver: the role of apoptosis
Tzirogiannis KN; Panoutsopoulos GI; Demonakou MD; Hereti RI; Alexandropoulou KN; Basayannis AC; Mykoniatis MG
Visa fler

Alla övriga publikationer

Conference publication: 2024;:a141-a142
P135 Altered hemostatic balance towards procoagulant state in pregnant women with systemic lupus erythematosus
Lini D; Gunnarsson I; Soutari N; Lalic-Cosic S; Nicholas AM; Chaireti R; Bremme K; Franceschini F; Svenungsson E; Andreoli L; Antovic A
Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:1468-1469
COAGULATION AND HAEMOSTASIS PARAMETERS IN PREGNANT WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND HEALTHY CONTROLS WITH AND WITHOUT PREECLAMPSIA
Lini D; Gunnarsson I; Soutari NMH; Lalic-Cosic S; Mc Nicholas A; Charieti R; Bremme K; Franceschini F; Svenungsson E; Andreoli L; Antovic A
Letter: EUROPEAN JOURNAL OF HAEMATOLOGY. 2023;110(2):224-225
Response to Caravita di Toritto and Rago
Chaireti R; Uttervall K; Luong V; Lund J; Kashif M; Gahrton G; Alici E; Nahi H; Afram G
Other: CASE REPORTS IN OBSTETRICS AND GYNECOLOGY. 2022;2022:7777445-4
A Case Report of Severe Coagulopathy in Antenatal COVID-19
Sand A; Chaireti R; Sennstrom M; Pettersson K; Magnusson M
Editorial comment: ANNALS OF INTERNAL MEDICINE. 2022;175(2):JC19
In patients hospitalized for COPD exacerbation, a PE diagnostic strategy plus usual care did not improve outcomes
Chaireti R
Conference publication: HAEMATOLOGICA. 2019;104:18
GLOBAL HEMOSTATIC METHODS IN PATIENTS WITH INHERITED HEMOPHILIA WITH INHIBITORS AND WITH ACQUIRED HEMOPHILIA; A TWO-CENTRE STUDY
Chaireti R; Hourani Soutari NM; Holmstrom M; Petrini P; Magnusson M; Ranta S; Zadro R; Pruner I; Antovic JP
Letter: THROMBOSIS RESEARCH. 2019;173:1-3
Presence of thrombophilia and levels of coagulation factors, coagulation inhibitors and TAFI do not affect global haemostasis or bleeding phenotype in patients with haemophilia A
Mikovic D; Pruner I; Antovic JP; Chaireti R
Letter: THROMBOSIS RESEARCH. 2018;172:51-53
Increasing thrombin generation during IVF treatment is correlated to hormonal changes, but not to TFPI
Bremme K; Soutari N; Antovic JP; Wramsby M; Chaireti R
Meeting abstract: BLOOD. 2018;132:2473
Combined Effect of By-Pass Agents and a Sequence Identical Analogue of Emicizumab on Fibrin Clot Turbidity and Structure in Factor VIII Deficient Plasma
Pruner I; Zong Y; Soutari NMH; Chaireti R; Antovic A; Antovic J
Letter: THROMBOSIS RESEARCH. 2018;168:145-147
Risk factors and obstetric outcomes in pregnancies complicated by pelvic vein thrombosis, and in the subsequent pregnancy
Bremme K; Hinnerdal SL; Sjoquist SH; Chaireti R
Conference publication: HAEMOPHILIA. 2018;24:100-101
Evaluation of a standardized protocol for thrombin generation using the calibrated automated thrombogram: a Scandinavian study
Ljungkvist M; Chaireti R; Holme PA; Larsen OH; Lassila R; Thornemo M; Strandberg K; Berntorp E; Zetterberg E
Book chapter: EMBOLIC DISEASES - UNUSUAL THERAPIES AND CHALLENGES. 2017;p.
Risk Factors, Treatment and Prevention of Venous Thromboembolism During Pregnancy and Postpartum
Chaireti R; Bremme K
Corrigendum: PLOS ONE. 2017;12(2):e0172185
Postpartum Hemorrhage in Women with Von Willebrand Disease - A Retrospective Observational Study (vol 11, e0164683, 2016)
Govorov I; Loefgren S; Chaireti R; Holmstroem M; Bremme K; Mints M
Meeting abstract: BLOOD. 2016;128(22):563
Difference in Fibrin Clot Structure in Haemophilia A and Haemophilia B
Luong V; Soutari N; Berndtsson M; Holmstrom M; Antovic JP; Chaireti R
Meeting abstract: BLOOD. 2016;128(22):1419
Age-Adjusted D-Dimer Cutoffs for DVT and Pulmonary Embolism: A Comparison of Five Assays
Farm M; Siddiqui A; Onelov L; Chaireti R; Holmstrom M; Antovic JP
Conference publication: HAEMATOLOGICA. 2016;101:10
POSTPARTUM HEMORRHAGE IN WOMEN WITH VON WILLEBRAND DISEASE - A RETROSPECTIVE OBSERVATIONAL STUDY
Govorov I; Lofgren S; Chaireti R; Bremme K; Holmstrom M; Mints M
Conference publication: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2015;13:614
Inflammatory and endothelial markers and their relations to the haemostatic potential during the menstrual cycle
Chaireti R; Lindahl TL; Bremme K; Larsson A
Conference publication: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2015;13:681
Thrombin generation in women undergoing ivf treatment is prolonged, but not enhanced compared to controls
Chaireti R; Bremme K
Conference publication: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2015;13:710
Thrombin generation in patients with mild factor VII deficiency measured in the presence of thromboplastins of different origin
Chaireti R; Arbring K; Persson E; Lindahl TL
Conference publication: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2015;13:710
Mutations in the F7 gene in Swedish patients with discrepant factor VII activity in the presence of thromboplastins of different origin
Chaireti R; Arbring K; Olsen OH; Persson E; Lindahl TL
Meeting abstract: CANCER RESEARCH. 2014;74(19):3518
TP53 mutations and MDM2 single nucleotide polymorphism 309T-G predicts outcome and treatment resistance in acute myeloid leukemia
Falk IJ; Willander K; Chaireti R; Lund J; Hermanson M; Green H; Soderkvist P; Lotfi K
Book: 2013
Thrombin generation in different cohorts : Evaluation of the haemostatic potential
Chaireti R
Conference publication: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2013;11:871
Higher thrombin generation during the luteal phase of a normal menstrual cycle does not depend on inflammatory activity
Chaireti R; Larsson A; Bremme K; Lindahl T
Conference publication: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2013;11:32-33
How do female hormone levels affect the haemostasis during the course of the menstrual cycle?
Chaireti R; Bremme K; Gustafsson KM; Lindahl TL
Conference publication: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2013;11:32
Do haemostatic parameters vary during the course of the menstrual cycle?
Chaireti R; Bremme K; Gustafsson KM; Lindahl TL
Conference publication: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2013;11:29
How do haemostatic variables affect thrombin generation during the course of the menstrual cycle?
Chaireti R; Bremme K; Gustafsson KM; Lindahl TL
Conference publication: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2013;11:697
First experience of structured introduction of new oral anticoagulants in a Swedish health care district: dabigatran as an alternative to warfarin in atrial fibrillation
Arbring K; Chaireti R; Janzon M; Uppugunduri S; Jansson K; Lindahl T
Conference publication: HEPATOLOGY. 2013;58:883A
Hypercoagulability in portal vein thrombosis is related to the presence of liver cirrhosis
Rajani R; Chaireti R; Bergquist A; Melin T; Friis-Liby I; Kapraali M; Kechagias S; Lindahl TL; Almer S
Letter: ANNALS OF CLINICAL PSYCHIATRY. 2012;24(2):176-177
Case report of anticonvulsant hypersensitivity syndrome complicated by a concomitant atypical pneumonia
Chaireti R; Nordstrom K
Conference publication: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2011;9:607
How are thrombin generation and thrombosis recurrence rates affected by age and gender? The linkoping study on thrombosis (LIST) - a 7 year follow-up
Chaireti R; Jennersjo C; Lindahl TL
Conference publication: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2011;9:607
Is thrombin generation at the time of an acute thromboembolic episode a predictor of recurrence risk? the linkoping study on thrombosis (LIST) - a 7-year follow-up
Chaireti R; Jennersjo C; Lindahl T
Meeting abstract: JOURNAL OF HEPATOLOGY. 2006;44:s139
The hepatoprotective role of ketanserin in acute cadmium liver injury
Panoutsopoulos GI; Tzirogiannis KN; Papadimas GK; Skaltsas SD; Demonakou MD; Hereti RI; Manta GA; Mykoniatis MG
Conference publication: TOXICOLOGY AND APPLIED PHARMACOLOGY. 2004;197(3):303
Effect of serotonin receptor blockage on liver regeneration after 60-70% partial hepatectomy
Tzirogiannis KN; Papadimas GK; Panoutsopoulos GI; Demonakou MD; Skaltsas SD; Hereti RI; Grypioti AD; Basagiannis AC; Manta GA; Mykoniatis MG
Conference publication: TOXICOLOGY AND APPLIED PHARMACOLOGY. 2004;197(3):302
Liver serotonin levels after 60-70% partial hepatectomy in the rat
Papadimas GK; Tzirogiannis KN; Panoutsopoulos GI; Grypioti AD; Skaltsas SD; Demonakou MD; Garyphallidis SP; Hereti RI; Papadopoulou-Daifoti Z; Mykoniatis MG
Visa fler

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI